Table 3.
All CRC Patients | Colon Cancer Patients | Rectal Cancer Patients | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene | Genotype | Controls a | Cases a | OR b | 95% CI | p-Value | Cases a | OR b | 95% CI | p-Value | Cases a | OR b | 95% CI | p-Value | HWE c |
SNP | Χ2, p-Value | ||||||||||||||
Czech Republic | |||||||||||||||
EME1 rs12450550 |
TT | 678 | 815 | Ref | 526 | Ref | 284 | Ref | 1.07, 0.58 | ||||||
TC | 410 | 570 | 1.19 | 1.00–1.40 | 0.05 | 363 | 1.17 | 0.97–1.40 | 0.11 | 198 | 1.20 | 0.96–1.50 | 0.11 | ||
CC | 73 | 108 | 1.24 | 0.90–1.70 | 0.20 | 64 | 1.15 | 0.80–1.65 | 0.46 | 41 | 1.38 | 0.91–2.09 | 0.13 | ||
TC+CC | 483 | 678 | 1.19 | 1.02–1.40 | 0.03 | 427 | 1.16 | 0.97–1.39 | 0.10 | 239 | 1.23 | 0.99–1.52 | 0.06 | ||
TT+TC | 1088 | 1385 | Ref | 889 | Ref | 482 | Ref | ||||||||
CC | 73 | 108 | 1.16 | 0.84–1.59 | 0.36 | 64 | 1.08 | 0.76–1.55 | 0.66 | 41 | 1.28 | 0.86–1.93 | 0.23 | ||
REV3L rs3204953 |
GG | 839 | 1049 | Ref | 666 | Ref | 371 | Ref | 4.68, 0.10 | ||||||
GA | 304 | 405 | 1.09 | 0.91–1.30 | 0.37 | 261 | 1.12 | 0.91–1.37 | 0.27 | 139 | 1.06 | 0.83–1.34 | 0.66 | ||
AA | 15 | 43 | 2.32 | 1.27–4.25 | 0.006 * | 30 | 2.59 | 1.36–4.91 | 0.004 * | 13 | 1.97 | 0.92–4.22 | 0.08 | ||
GA+AA | 319 | 448 | 1.14 | 0.96–1.36 | 0.13 | 291 | 1.19 | 0.98–1.44 | 0.08 | 152 | 1.10 | 0.87–1.39 | 0.42 | ||
GG+GA | 1143 | 1454 | Ref | 927 | Ref | 510 | Ref | ||||||||
AA | 15 | 43 | 2.28 | 1.24–4.17 | 0.008 * | 30 | 2.52 | 1.33–4.77 | 0.005 * | 13 | 1.95 | 0.91–4.18 | 0.09 | ||
Austria | |||||||||||||||
POLQ rs1381057 |
CC | 372 | 413 | Ref | 267 | Ref | 134 | Ref | 1.49, 0.47 | ||||||
CT | 349 | 423 | 1.09 | 0.90–1.34 | 0.38 | 250 | 1.00 | 0.80–1.25 | 1.00 | 166 | 1.32 | 1.01–1.74 | 0.04 | ||
TT | 99 | 114 | 1.05 | 0.77–1.42 | 0.76 | 65 | 0.93 | 0.65–1.32 | 0.68 | 49 | 1.40 | 0.94–2.08 | 0.10 | ||
CT+TT | 448 | 537 | 1.08 | 0.90–1.31 | 0.40 | 315 | 0.98 | 0.80–1.22 | 0.89 | 215 | 1.34 | 1.04–1.74 | 0.03 | ||
CC+CT | 721 | 836 | Ref | 517 | Ref | 300 | Ref | ||||||||
TT | 99 | 114 | 1.00 | 0.75–1.34 | 0.98 | 65 | 0.93 | 0.66–1.29 | 0.66 | 49 | 1.21 | 0.84–1.75 | 0.32 | ||
REV1 rs3087399 |
AA | 593 | 673 | Ref | 414 | Ref | 243 | Ref | 0.02, 0.99 | ||||||
AG | 208 | 259 | 1.10 | 0.89–1.36 | 0.39 | 151 | 1.04 | 0.81–1.32 | 0.78 | 105 | 1.25 | 0.95–1.66 | 0.11 | ||
GG | 19 | 18 | 0.83 | 0.43–1.60 | 0.58 | 17 | 1.27 | 0.65–2.48 | 0.48 | 1 | 0.13 | 0.02–0.96 | 0.05 | ||
AG+GG | 227 | 277 | 1.08 | 0.87–1.32 | 0.50 | 168 | 1.06 | 0.83–1.34 | 0.65 | 106 | 1.16 | 0.88–1.53 | 0.30 | ||
AA+AG | 801 | 932 | Ref | 565 | Ref | 348 | Ref | ||||||||
GG | 19 | 18 | 0.81 | 0.42–1.56 | 0.53 | 17 | 1.26 | 0.65–2.44 | 0.50 | 1 | 0.12 | 0.02–090 | 0.04 |
OR—odds ratio; CI—confidence interval. Nominally significant results are in bold. Results that passed the Benjamini–Hochberg test for multiple comparisons are marked with an asterisk. a Numbers may not add up to 100% of subjects due to genotyping failure. All of the samples that did not give a reliable result in the first round of genotyping were retested in up to two additional rounds. Samples failing these procedures were omitted from the analysis. b Logistic regression analysis values are adjusted for age. c X2 and p-values for the deviation of the observed and of the numbers expected from the Hardy–Weinberg equilibrium (HWE) in the controls.